WELL Health Technologies' Subsidiary Raises $44 Million in Series B Financing

Dow Jones
2025/10/31
 

By Adriano Marchese

 

WELL Health Technologies said its subsidiary has received 62 million Canadian dollars ($44.3 million) in a series B investment funding round ahead of a planned public listing.

The Canadian digital healthcare company said Friday that its majority-owned subsidiary Wellstar Technologies has entered into agreements for share investments at an offering price of C$1.50 apiece.

WELL said that the series B financing--a type of fundraising used for early-stage companies--is supported by three of Canadian fund investors, Mawer Investment Management, Edgepoint Wealth Management and Picton Investments.

The company plans to use the funds towards future acquisitions, artificial intelligence-related offerings, organic growth initiatives and general corporate purposes.

The financing is expected to close early in December, and Wellstar is targeting a public listing sometime in 2026.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

October 31, 2025 08:52 ET (12:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10